COL5A1 and ovarian carcinoma: Notably, Zhang et al. (2021) reported a correlation between COL5A1 overexpression and tumour-infiltrating immune cells (TIICs), proposing its utility in predicting ovarian cancer progression and paclitaxel (PTX) resistance (Zhang et al., 2021).